Patents by Inventor Ketan Desai

Ketan Desai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
    Patent number: 11779583
    Abstract: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: October 10, 2023
    Assignee: EMORY UNIVERSITY
    Inventors: Michael G. Natchus, Richard Arrendale, Dennis C. Liotta, Ketan Desai, Hyunsuk Shim
  • EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections
    Publication number: 20220409518
    Abstract: Compositions comprising emu oil as a vehicle for the delivery of other active ingredients for the treatment of cosmetic and other skin imperfections such as acne, wrinkles, and hair loss are disclosed. Methods of treating cosmetic and other skin imperfections using the compositions are also disclosed.
    Type: Application
    Filed: August 25, 2022
    Publication date: December 29, 2022
    Inventors: Scott A. Weisenfluh, Ketan Desai, Sandra Kroposky
  • Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
    Patent number: 11285151
    Abstract: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: March 29, 2022
    Assignee: EMORY UNIVERSITY
    Inventors: Michael G. Natchus, Richard Arrendale, Dennis Liotta, Ketan Desai, Hyunsuk Shim
  • Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction
    Publication number: 20220040174
    Abstract: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
    Type: Application
    Filed: August 23, 2019
    Publication date: February 10, 2022
    Inventors: Michael G. Natchus, Richard Arrendale, Dennis Liotta, Ketan Desai, Hyunsuk Shim
  • TRICYCLIC AMINO CONTAINING COMPOUNDS FOR TREATMENT OR PREVENTION OF SYMPTOMS ASSOCIATED WITH ENDOCRINE DYSFUNCTION
    Publication number: 20210401836
    Abstract: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
    Type: Application
    Filed: August 31, 2021
    Publication date: December 30, 2021
    Applicant: EMORY UNIVERSITY
    Inventors: Michael G. Natchus, Richard Arrendale, Dennis C. Liotta, Ketan Desai, Hyunsuk Shim
  • Use of IL13 for prevention and treatment of COVID19
    Publication number: 20210393743
    Abstract: A method of use for prevention and treatment of COVID-19 using IL13 is described.
    Type: Application
    Filed: May 30, 2021
    Publication date: December 23, 2021
    Inventor: Ketan Desai
  • Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
    Patent number: 10632120
    Abstract: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: April 28, 2020
    Assignee: Emory University
    Inventors: Michael G. Natchus, Richard Arrendale, Dennis Liotta, Ketan Desai, Hyunsuk Shim
  • Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction
    Publication number: 20190381042
    Abstract: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
    Type: Application
    Filed: August 26, 2019
    Publication date: December 19, 2019
    Inventors: Michael G. Natchus, Richard Arrendale, Dennis Liotta, Ketan Desai, Hyunsuk Shim
  • Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction
    Publication number: 20190374541
    Abstract: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
    Type: Application
    Filed: August 23, 2019
    Publication date: December 12, 2019
    Inventors: Michael G. Natchus, Richard Arrendale, Dennis Liotta, Ketan Desai, Hyunsuk Shim
  • INSTRUMENT FOR MEASURING STRUCTURAL CHANGE AND DAMAGE IN LUPUS
    Publication number: 20180116611
    Abstract: A method of quantifying structural damage in Lupus is described. The method can be used to assess progress in clinical trials or in clinical practice.
    Type: Application
    Filed: November 3, 2016
    Publication date: May 3, 2018
    Inventor: Ketan Desai
  • EMU Oil In Combination With Other Active Ingredients For Treating Skin Imperfections
    Publication number: 20170304187
    Abstract: Compositions comprising emu oil as a vehicle for the delivery of other active ingredients for the treatment of cosmetic and other skin imperfections such as acne, wrinkles, and hair loss are disclosed. Methods of treating cosmetic and other skin imperfections using the compositions are also disclosed.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Inventors: Scott A. Weisenfluh, Ketan Desai, Sandra Kroposky
  • Emu oil in combination with other active ingredients for treating skin imperfections
    Patent number: 9757324
    Abstract: Compositions comprising emu oil as a vehicle for the delivery of other active ingredients for the treatment of cosmetic and other skin imperfections such as acne, wrinkles, and hair loss are disclosed. Methods of treating cosmetic and other skin imperfections using the compositions are also disclosed.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: September 12, 2017
    Inventors: Scott A. Weisenfluh, Ketan Desai, Sandra Kroposky
  • Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
    Patent number: 9737553
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: August 22, 2017
    Assignee: Levolta Pharmaceuticals, Inc.
    Inventor: Ketan Desai
  • EMU OIL IN COMBINATION WITH OTHER ACTIVE INGREDIENTS FOR TREATING SKIN IMPERFECTIONS
    Publication number: 20160184215
    Abstract: Compositions comprising emu oil as a vehicle for the delivery of other active ingredients for the treatment of cosmetic and other skin imperfections such as acne, wrinkles, and hair loss are disclosed. Methods of treating cosmetic and other skin imperfections using the compositions are also disclosed.
    Type: Application
    Filed: July 24, 2015
    Publication date: June 30, 2016
    Inventors: Scott A. Weisenfluh, Ketan Desai, Sandra Kroposky
  • Small molecule inhibitors of protein kinases
    Patent number: 9212143
    Abstract: Compounds that modulate, for example, that inhibit, syk kinase, and, optionally other kinases. The compounds can be used to treat a variety of disorders, including inflammatory disorders and autoimmune disorders.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: December 15, 2015
    Assignee: LEVOLTA PHARMACEUTICALS, INC.
    Inventors: Ketan Desai, Renee Desai
  • EMU oil in combination with other active ingredients for treating skin imperfections
    Patent number: 9138446
    Abstract: Compositions comprising emu oil as a vehicle for the delivery of other active ingredients for the treatment of cosmetic and other skin imperfections such as acne, wrinkles, and hair loss are disclosed. Methods of treating cosmetic and other skin imperfections using the compositions are also disclosed.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: September 22, 2015
    Inventors: Scott Alan Weisenfluh, Ketan Desai, Sandra Kroposky
  • Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
    Patent number: 9012432
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: April 21, 2015
    Assignee: Levolta Pharmaceuticals, Inc.
    Inventor: Ketan Desai
  • Co-administration of steroids and Zoledronic acid to prevent and treat side effects from Zoledronic acid infusion
    Patent number: 8946199
    Abstract: Zoledronic Acid is used for treatment of hypercalcemia of malignancy, for the treatment of bone metastasis associated with malignancies such as prostate and breast cancer, for the prevention of and treatment of osteoporosis and for the treatment of Paget's disease. Administration of Zoledronic Acid is complicated by what is described as “post-dosing syndrome” (PDS) and osteonecrosis of the jaw (ONJ). Inflammation may be the cause of these side effects, which could be decreased by the co-administration of steroids. This application is a method of use patent for the co-administration of steroids (oral, IV, IM, rectal, or by inhalation) with Zoledronic Acid and a composition of matter patent for mixing Methyl Prednisolone with Zoledronic Acid for infusion.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: February 3, 2015
    Inventor: Ketan Desai
  • CO-ADMINISTRATION OF STEROIDS AND ZOLEDRONIC ACID TO PREVENT AND TREAT OSTEOARTHRITIS
    Publication number: 20150031649
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Application
    Filed: October 14, 2014
    Publication date: January 29, 2015
    Applicant: Voltarra Pharmaceuticals, Inc.
    Inventor: Ketan Desai
  • Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
    Patent number: 8859530
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: October 14, 2014
    Assignee: Voltarra Pharmaceuticals, Inc.
    Inventor: Ketan Desai